<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2024000100006</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Evaluation of a prepared combined inactivated vaccine against hemorrhagic disease virus 2 and Clostridium perfringens type A infections in rabbit]]></article-title>
<article-title xml:lang="es"><![CDATA[Evaluación de una vacuna preparada combinada inactivada contra la infección en conejos del virus de la enfermedad hemorrágica tipo 2 y el Clostridium perfringens tipo A]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Abotaleb]]></surname>
<given-names><![CDATA[Mahmoud M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tawfik]]></surname>
<given-names><![CDATA[Rasha G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Omar]]></surname>
<given-names><![CDATA[Dalia M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mohamed]]></surname>
<given-names><![CDATA[Farida H.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aly]]></surname>
<given-names><![CDATA[Shereen M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Khalaf]]></surname>
<given-names><![CDATA[Noura M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nassif]]></surname>
<given-names><![CDATA[Samir A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Agricultural Research Center (ARC) Central Laboratory for Evaluation of Veterinary Biologics (CLEVB) ]]></institution>
<addr-line><![CDATA[Cairo ]]></addr-line>
<country>Egypt</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Alexandria University Faculty of Veterinary Medicine Department of Microbiology]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Egypt</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Agriculture Research Center (ARC) Animal Health Research Institute (AHRI) Department of immunology]]></institution>
<addr-line><![CDATA[Dokki ]]></addr-line>
<country>Egypt</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Agriculture Research Center (ARC) Veterinary Serum and Vaccine Research Institute (VSVRI) Department of Anaerobic bacteria]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>33</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2024000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2024000100006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2024000100006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Rabbit hemorrhagic disease virus 2 and Clostridium perfringens type A cause infections in rabbit. Vaccines are considered an effective strategy for fighting these infections. Nowadays, the demand for using a nanoparticle adjuvant as (Montanide&#8482; IMS) is increased due to its ability for enhancing both humoral and cell mediated immunity and, in addition, it can be administrated through different routes. An inactivated vaccine against rabbit hemorrhagic disease virus 2 and Clostridium perfringens type A which adjuvanted by Montanide&#8482; IMS 1313 N VG PR (IMS 1313) was developed. The prepared vaccine was evaluated in rabbits for sterility, safety and potency via two different routes of vaccination. Oral administration of inactivated vaccine was evaluated as an alternative route to subcutaneous vaccination. The results revealed that rabbits vaccinated by subcutaneous route exhibited satisfactory antibody and antitoxin titer against rabbit hemorrhagic disease virus 2 and Clostridium perfringens type A, respectively, from 2nd week post vaccination and reached the peak at 3th week post vaccination. On the other hand, antibody and antitoxin titer of orally vaccinated rabbits didn't reach the satisfactory level. Rabbits vaccinated orally were not protected against virulent rabbit hemorrhagic disease virus 2, with 30% protection, while rabbits vaccinated subcutaneously showed satisfactory protection (90%). Serum nitric oxide and lysozyme activity had significant differences between vaccinated and control rabbits. The level of nitric oxide and lysozyme in sera of subcutaneously vaccinated rabbits was higher than that of orally vaccinated rabbits. Interleukin-6 and tumor necrosis factor-&#593; were determined in the spleen of vaccinated rabbits, significant differences were obtained between subcutaneously and orally vaccinated rabbits. It was concluded that the combined vaccine is potent when inoculated by subcutaneous route in contrast to the oral route. The Montanide&#8482; IMS 1313 adjuvant is a product that can be used for rabbit vaccine preparation.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN El virus de la enfermedad hemorrágica del conejo tipo 2 y el Clostridium perfringens tipo A causan infecciones en conejos. Las vacunas se consideran una estrategia eficaz para combatir estas infecciones. Hoy en día, la demanda para el uso de un adyuvante de nanopartículas como Montanide&#8482; IMS es cada vez mayor debido a su capacidad para mejorar la inmunidad humoral y la mediada por células, y a la posibilidad de administrarla por diferentes vías. En este estudio se desarrolló una vacuna inactivada contra el virus de la enfermedad hemorrágica del conejo tipo 2 y el Clostridium perfringens tipo A, adyuvada con Montanide&#8482; IMS 1313 N VG PR (IMS 1313). Se evaluó la vacuna preparada en cuanto a esterilidad, seguridad y potencia en conejos mediante dos vías diferentes de vacunación. Se evaluó la administración oral de la vacuna inactivada como vía alternativa a la vacunación subcutánea. Los resultados revelaron que los conejos vacunados por vía subcutánea presentaban títulos satisfactorios de anticuerpos y antitoxinas contra el virus 2 de la enfermedad hemorrágica del conejo y el Clostridium perfringens tipo A, respectivamente, a partir de la segunda semana de vacunación y alcanzaron el máximo en la tercera semana. En cambio, los títulos de anticuerpos y antitoxinas de los conejos vacunados por vía oral no alcanzaron un nivel satisfactorio. Los conejos vacunados por vía oral no mostraron protección contra el virus virulento de la enfermedad hemorrágica del conejo tipo 2, con un 30% de protección, mientras que los conejos vacunados por vía subcutánea mostraron una protección satisfactoria (90%). El óxido nítrico sérico y la actividad de la lisozima presentaron diferencias significativas entre los conejos vacunados y los controles. El nivel de óxido nítrico y lisozima en el suero de los conejos vacunados por vía subcutánea fue superior al de los conejos vacunados por vía oral. Se determinaron la interleucina-6 y el factor de necrosis tumoral-&#593; en el bazo de los conejos vacunados, y se obtuvieron diferencias significativas entre los conejos vacunados por la vía subcutánea y la oral. Se concluyó que la vacuna combinada es potente cuando se inocula por vía subcutánea en contraste con la vía oral. El adyuvante Montanide&#8482; IMS 1313 es un producto que puede utilizarse para la preparación de vacunas para conejos.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[combined vaccines]]></kwd>
<kwd lng="en"><![CDATA[humoral immune response]]></kwd>
<kwd lng="en"><![CDATA[IL-6]]></kwd>
<kwd lng="en"><![CDATA[rabbits]]></kwd>
<kwd lng="en"><![CDATA[rabbit hemorrhagic disease virus]]></kwd>
<kwd lng="es"><![CDATA[vacunas combinadas]]></kwd>
<kwd lng="es"><![CDATA[inmunidad humoral]]></kwd>
<kwd lng="es"><![CDATA[IL-6]]></kwd>
<kwd lng="es"><![CDATA[conejos]]></kwd>
<kwd lng="es"><![CDATA[virus de la enfermedad hemorrágica del conejo]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemida]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Khaliel]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Ebshahy]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Abotaleb]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative Study between the Isolated Rabbit Hemorrhagic Septicemia Virus and Available Vaccine Strain]]></article-title>
<source><![CDATA[Inter J Vet Sci]]></source>
<year>2020</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>189-95</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capucci]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cavadini]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Schiavitto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lombardi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lavazza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increased pathogenicity in rabbit hemorrhagic disease virus type 2 (RHDV2)]]></article-title>
<source><![CDATA[Vet Rec]]></source>
<year>2017</year>
<volume>180</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>426</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>World Organisation for Animal Health (OIE)</collab>
<article-title xml:lang=""><![CDATA[Rabbit hemorrhagic disease]]></article-title>
<source><![CDATA[Manual of diagnostic tests and vaccines for terrestrial animals]]></source>
<year>2018</year>
<page-range>1389-406</page-range><publisher-loc><![CDATA[París ]]></publisher-loc>
<publisher-name><![CDATA[OIE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saadh]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lafi]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Dahadha]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Albannan]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunogenicity of newly developed vaccine against Clostridium perfringens alpha-toxin in rabbits and cattle]]></article-title>
<source><![CDATA[Vet World]]></source>
<year>2022</year>
<volume>15</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1617-23</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Miao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunogenicity and Safety of Childhood Combination Vaccines A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[Vaccines]]></source>
<year>2022</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>472</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abido]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Abotaleb]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Nahed]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ayman]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Aziza]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protective efficacy of an inactivated vaccine against rabbit hemorrhagic disease virus 2 prepared from a local isolate in Egypt]]></article-title>
<source><![CDATA[VacciMonitor]]></source>
<year>2020</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>143-50</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El-Maghraby]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Abd El-Moneim]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Abd El-Moneam]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Khalaf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abo-Dalal]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Omar]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preparation and evaluation of locally prepared inactivated combined vaccine of rabbit haemorrhagic disease virus, Pasteurella multocida and Clostridium perfringens type A]]></article-title>
<source><![CDATA[Bioscience Research]]></source>
<year>2019</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>3973-86</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[SI]]></given-names>
</name>
<name>
<surname><![CDATA[Lillehoj]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Lillehoj]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Bertrand]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Montanide IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina]]></article-title>
<source><![CDATA[Vet Parasitol]]></source>
<year>2011</year>
<volume>182</volume>
<numero>2-4</numero>
<issue>2-4</issue>
<page-range>163-70</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ragland]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Criss]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From bacterial killing to immune modulation Recent insights into the functions of lysozyme]]></article-title>
<source><![CDATA[PLoS Pathog]]></source>
<year>2017</year>
<volume>13</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soufli]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Toumi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rafa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Touil-Boukoffa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases]]></article-title>
<source><![CDATA[World J Gastrointest Pharmacol Ther]]></source>
<year>2016</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>353-60</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Swaggerty]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Kaiser]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rothwell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pevzner]]></surname>
<given-names><![CDATA[IY]]></given-names>
</name>
<name>
<surname><![CDATA[Kogut]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heterophil cytokine mRNA profiles from genetically distinct lines of chickens with differential heterophil-mediated innate immune responses]]></article-title>
<source><![CDATA[Avian Pathol]]></source>
<year>2006</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>102-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peeters]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Vantrappen]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors influencing lysozyme determination by lysoplate method]]></article-title>
<source><![CDATA[Clin Chim Acta]]></source>
<year>1977</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>217-25</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Asim]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Jiang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Zhong]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Shahzad]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitric oxide in both bronchoalveolar lavage fluid and serum is associated with pathogenesis and severity of antigen induced pulmonary inflammation in rats]]></article-title>
<source><![CDATA[J Asthma]]></source>
<year>2010</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>135-44</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yuan]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Statistical analysis of real-time PCR data]]></article-title>
<source><![CDATA[BMC Bioinformatics]]></source>
<year>2006</year>
<volume>7</volume>
<page-range>85</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schnupf]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sansonetti]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quantitative RT-PCR profiling of the Rabbit Immune Response Assessment of Acute Shigella flexneri Infection]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2012</year>
<volume>7</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godornes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leader]]></surname>
<given-names><![CDATA[BT]]></given-names>
</name>
<name>
<surname><![CDATA[Molini]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Centurion-Lara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lukehart]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quantitfication of rabbit cytokine mRNA by Real-Time RTPCR]]></article-title>
<source><![CDATA[Cytokine]]></source>
<year>2007</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El-Akkad]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Zaki]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[El-Nagar]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Refaat]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular evaluation of prepared Rift Valley Fever (RVF) vaccine using Montanide Gel 02 and its effect on the genetic material]]></article-title>
<source><![CDATA[Benha J Appl Sci]]></source>
<year>2022</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>13-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riffault]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Deplanche]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dubuquoy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Durand]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Soulestin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus]]></article-title>
<source><![CDATA[Vaccine]]></source>
<year>2010</year>
<volume>28</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>3722-34</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>United States Department of Agriculture</collab>
<source><![CDATA[Center for Veterinary Biologics Notice No 02-25, conditional licenses for products containing Clostridium perfringens type A]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Washington DC ]]></publisher-loc>
<publisher-name><![CDATA[USDA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El-Bagoury]]></surname>
<given-names><![CDATA[GF]]></given-names>
</name>
<name>
<surname><![CDATA[El-Habbaa]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Ibrahim]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Noha]]></surname>
<given-names><![CDATA[EY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluating humoral immune response of sheep vaccinated with inactivated RVF virus vaccine using oil nanoparticles adjuvant in comparison with aluminum hydroxide gel]]></article-title>
<source><![CDATA[Benha Vet Med J]]></source>
<year>2017</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>174-82</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deville]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arous]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Bertrand]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Borisov]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dupuis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry]]></article-title>
<source><![CDATA[Procedia Vaccinol]]></source>
<year>2012</year>
<numero>6</numero>
<issue>6</issue>
<page-range>85-92</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stancu]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[C&#259;rpini&#537;an]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ghi&#537;e]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marcu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pentea]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Dumitrescu]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical chemistry, haematology, immune response and histological evaluation of rabbits after immunization and challenge with rabbit haemorrhagic disease (RHD) virus]]></article-title>
<source><![CDATA[World Rabbit Sci]]></source>
<year>2017</year>
<volume>25</volume>
<page-range>357-65</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reda]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[AboSalem]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[El Zoghby]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Attia]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Emam]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immunohistochemical studies on thymus gland of rabbits after vaccination with viral hemorrhagic septicemia vaccine]]></article-title>
<source><![CDATA[Benha Vet Med J]]></source>
<year>2019</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>203-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
